NASDAQ:ACOG Alpha Cognition (ACOG) Stock Price, News & Analysis $4.99 -0.09 (-1.77%) As of 04/3/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrendsBuy This Stock About Alpha Cognition Stock (NASDAQ:ACOG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alpha Cognition alerts:Sign Up Key Stats Today's Range$4.80▼$5.2950-Day Range$4.85▼$6.6152-Week Range$4.66▼$7.00Volume14,689 shsAverage Volume76,691 shsMarket Capitalization$79.94 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingBuy Company OverviewAlpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.Read More… Remove Ads Alpha Cognition Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreACOG MarketRank™: Alpha Cognition scored higher than 35% of companies evaluated by MarketBeat, and ranked 713th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAlpha Cognition has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlpha Cognition has only been the subject of 2 research reports in the past 90 days.Read more about Alpha Cognition's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Cognition is -1.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Cognition is -1.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Alpha Cognition's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACOG. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Cognition does not currently pay a dividend.Dividend GrowthAlpha Cognition does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ACOG. News and Social Media2.4 / 5News Sentiment0.38 News SentimentAlpha Cognition has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Alpha Cognition this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Alpha Cognition to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alpha Cognition insiders have not sold or bought any company stock.Percentage Held by Insiders31.52% of the stock of Alpha Cognition is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Alpha Cognition's insider trading history. Receive ACOG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter. Email Address ACOG Stock News HeadlinesQ1 EPS Estimates for Alpha Cognition Lifted by HC WainwrightApril 4 at 1:35 AM | americanbankingnews.comAlpha Cognition (NASDAQ:ACOG) Earns Buy Rating from HC WainwrightApril 2 at 1:27 AM | americanbankingnews.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 4, 2025 | Porter & Company (Ad)Contrasting Alpha Cognition (ACOG) & Its CompetitorsApril 1 at 1:57 AM | americanbankingnews.comAlpha Cognition Inc. (ACOG) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comAlpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating OverviewMarch 31, 2025 | businesswire.comAlpha Cognition (ACOG) Expected to Announce Quarterly Earnings on WednesdayMarch 31, 2025 | americanbankingnews.comAlpha Cognition (ACOG) & The Competition Financial SurveyMarch 31, 2025 | americanbankingnews.comSee More Headlines ACOG Stock Analysis - Frequently Asked Questions How have ACOG shares performed this year? Alpha Cognition's stock was trading at $5.86 at the beginning of 2025. Since then, ACOG stock has decreased by 14.8% and is now trading at $4.99. View the best growth stocks for 2025 here. How were Alpha Cognition's earnings last quarter? Alpha Cognition, Inc. (NASDAQ:ACOG) posted its quarterly earnings data on Monday, March, 31st. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.03. When did Alpha Cognition IPO? Alpha Cognition (ACOG) raised $50 million in an IPO on Tuesday, November 12th 2024. The company issued 8,695,653 shares at $5.75 per share. When does Alpha Cognition's lock-up period expire? Alpha Cognition's lock-up period expires on Monday, May 12th. Alpha Cognition had issued 8,695,653 shares in its initial public offering on November 12th. The total size of the offering was $50,000,005 based on an initial share price of $5.75. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period. How do I buy shares of Alpha Cognition? Shares of ACOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/31/2025Today4/04/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ACOG CIK1655923 WebN/A Phone(858) 344-4375FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$20.00 High Stock Price Target$20.00 Low Stock Price Target$20.00 Potential Upside/Downside+300.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($2.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,770,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-344.17% Debt Debt-to-Equity RatioN/A Current Ratio1.50 Quick Ratio1.50 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($1.08) per share Price / Book-4.62Miscellaneous Outstanding Shares16,020,000Free Float10,970,000Market Cap$79.94 million OptionableN/A Beta2.50 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:ACOG) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
